Premature Ovarian Failure Clinical Trials

Find Premature Ovarian Failure Clinical Trials Near You

Application of Autologous Adipose Stromal Vascular Fraction in the Treatment of Premature Ovarian Insufficiency

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

A single-center, prospective, randomised controlled clinical trial (1:1 treatment ratio), designed to investigate the efficacy and safety of autologous SVF in improving the pregnancy outcome of infertile patients with POI.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 20
Maximum Age: 39
Healthy Volunteers: f
View:

• Women aged ≥20 and ≤39 years who have childbearing requirements.

• Cessation of menstruation or oligomenorrhea for at least 4 months

• Serum level of basal follicle stimulating hormone (FSH) \>25 U/L at least 2 times (during the second to fourth day of the menstrual cycle or during amenorrhea; The interval between the two tests is 4 weeks)

• Serum level of Anti-Mullerian hormone (AMH) ≤1.1 ng/ml

• Women with intact uterus and bilateral adnexa.

• Voluntary participation and informed consent obtained.

Locations
Other Locations
China
Peking University Third Hospital
RECRUITING
Beijing
Contact Information
Primary
Rui Yang, M.D.
yrjeff@126.com
+86-010-82265080
Backup
Yaodong Zhang, Bachelor
zyddoctor99@163.com
Time Frame
Start Date: 2024-07-23
Estimated Completion Date: 2026-12-30
Participants
Target number of participants: 260
Treatments
Experimental: Group A-SVF group
Qualified participants will be randomized into either of two groups. Participants in this group will undergo lower abdominal liposuction, preparation of SVF and ovarian injection, other standard assisted reproductive treatments are similar and parallel between two groups.
Other: Group B-Control group
Qualified participants will be randomized into either of two groups. Participants in this group will be treated according to the current clinical routine of the reproductive center, other standard assisted reproductive treatments are similar and parallel between two groups.
Related Therapeutic Areas
Sponsors
Leads: Rui Yang

This content was sourced from clinicaltrials.gov